Chemours (CC) Other Accumulated Expenses (2016 - 2025)
Chemours has reported Other Accumulated Expenses over the past 11 years, most recently at $150.0 million for Q4 2025.
- Quarterly results put Other Accumulated Expenses at $150.0 million for Q4 2025, up 30.43% from a year ago — trailing twelve months through Dec 2025 was $150.0 million (up 30.43% YoY), and the annual figure for FY2025 was $150.0 million, up 30.43%.
- Other Accumulated Expenses for Q4 2025 was $150.0 million at Chemours, up from $107.0 million in the prior quarter.
- Over the last five years, Other Accumulated Expenses for CC hit a ceiling of $222.0 million in Q2 2025 and a floor of $65.0 million in Q1 2021.
- Median Other Accumulated Expenses over the past 5 years was $130.5 million (2023), compared with a mean of $138.2 million.
- Peak annual rise in Other Accumulated Expenses hit 187.67% in 2022, while the deepest fall reached 53.25% in 2022.
- Chemours' Other Accumulated Expenses stood at $173.0 million in 2021, then increased by 12.14% to $194.0 million in 2022, then crashed by 33.51% to $129.0 million in 2023, then fell by 10.85% to $115.0 million in 2024, then surged by 30.43% to $150.0 million in 2025.
- The last three reported values for Other Accumulated Expenses were $150.0 million (Q4 2025), $107.0 million (Q3 2025), and $222.0 million (Q2 2025) per Business Quant data.